Hyperglycemic Crisis: Putting Recommendation Into Practice | Recording-Hyperglycemic Crisis: Putting Recommendation Into Practice

Video Transcription

Video Summary

In a recent ADA webinar focusing on hyperglycemic crises, namely diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar state (HHS), experts discussed the epidemiology, diagnosis, and management of these conditions. Dr. Ninh Ninh Aung introduced the session, highlighting updates on inpatient glycemic order protocols. Dr. Robert Ruchakoff traced the historical understanding of DKA, noting significant reductions in mortality rates with modern management. Dr. Guillermo Umphires presented the latest consensus report on hyperglycemic crises, which emphasizes the increasing incidence of DKA, particularly in type 2 diabetes, and offers updated treatment guidelines like using lactated Ringer's in place of normal saline for better outcomes. An important focus was on euglycemic DKA, primarily linked to SGLT2 inhibitors, which requires early glucose infusion and modified insulin protocols. Dr. Cecilia Lo Wang stressed careful monitoring and protocol implementation in hospital settings, especially for patients at risk due to the use of SGLT2 inhibitors. They addressed questions about adjusting treatment protocols, emphasizing the use of beta-hydroxybutyrate over acetoacetate for monitoring DKA resolution and the consideration of subcutaneous insulin for mild cases. Overall, the session underscored the importance of updated protocols and close monitoring to effectively manage and prevent complications arising from hyperglycemic emergencies.

Keywords

ADA webinar

hyperglycemic crises

diabetic ketoacidosis

DKA

hyperglycemic hyperosmolar state

HHS

SGLT2 inhibitors

euglycemic DKA

lactated Ringer's

beta-hydroxybutyrate

subcutaneous insulin

glycemic order protocols